Four Decades for Justice
Nicholas A. Dorsey focuses his practice on representing corporate issuers and borrowers, and financial institutions, lenders and other parties, in public and private offerings of securities, loan transactions and other financing transactions. He also represents companies in mergers and acquisitions and regularly advises clients in connection with public disclosure and corporate matters. Additionally, Mr. Dorsey dedicates a significant portion of his practice to providing commercial and strategic advice to startup, early‑stage and founder‑led companies and investors in such companies. Clients regularly seek his counsel for the practical, commercial advice he offers with respect to their most challenging matters.
In addition to traditional capital markets offerings and banking transactions, Mr. Dorsey’s financing practice includes advising on liability management transactions and asset financings and securitizations. He has extensive cross‑border experience and counts multiple international companies and financial institutions among his diverse client base.
Notable work highlights include:
Mr. Dorsey has been recognized for his work in capital markets by Chambers USA, Chambers Global, The Legal 500 US and IFLR1000. He has been named to Bloomberg Law’s “40 Under 40” list and was named the “Equity Capital Markets Lawyer of the Year” by IFLR1000 in its United States Awards and a “Rising Star” by Law360, recognizing him as one of five outstanding capital markets lawyers in the nation under the age of 40. Mr. Dorsey’s representations of the Founders of Palantir in the company’s direct listing and PG&E in its $5.5 billion DIP financing have been featured as the “Equity Capital Markets Deal of the Year” and “Banking and Finance Deal of the Year,” respectively, by IFLR1000.
Mr. Dorsey is a frequent speaker and author on a range of finance topics. He has served as Contributing Editor of multiple editions of Chambers’ Acquisition Finance Guide and authored chapters on the U.S. acquisition finance market. In addition, Mr. Dorsey authored the “Special Considerations for Non-EU Issuers” chapter in the Third Edition of European Securities Law and co‑authored an article entitled “SPAC Transactions in the United States” in The Legal 500’s “Mergers & Acquisitions Country Comparative Guide.” He has spoken at events such as the International Bar Association's “From Start Up to IPO” and “Global Entrepreneurship” conferences, the Practising Law Institute’s “Institute on Securities Regulation” and TechGC’s First-Time GC Summit.
Mr. Dorsey is a member of the International Bar Association and serves as the North American Regional Forum Liaison Officer of the Closely Held Companies Committee.
Mr. Dorsey was born in Canton, Ohio. He received a B.S. and M.Acc. summa cum laude from Case Western Reserve University in 2006 and a J.D. summa cum laude from Cornell Law School in 2009, where he was a Notes Editor of the Law Review and was elected to the Order of the Coif.
Mr. Dorsey joined Cravath in 2009 and was elected a partner in 2017. He worked in the Firm’s London office from 2011 to 2013 and is currently based in the Firm’s New York office.
In addition to traditional capital markets offerings and banking transactions, Mr. Dorsey’s financing practice includes advising on liability management transactions and asset financings and securitizations. He has extensive cross‑border experience and counts multiple international companies and financial institutions among his diverse client base.
Notable work highlights include:
Mr. Dorsey has been recognized for his work in capital markets by Chambers USA, Chambers Global, The Legal 500 US and IFLR1000. He has been named to Bloomberg Law’s “40 Under 40” list and was named the “Equity Capital Markets Lawyer of the Year” by IFLR1000 in its United States Awards and a “Rising Star” by Law360, recognizing him as one of five outstanding capital markets lawyers in the nation under the age of 40. Mr. Dorsey’s representations of the Founders of Palantir in the company’s direct listing and PG&E in its $5.5 billion DIP financing have been featured as the “Equity Capital Markets Deal of the Year” and “Banking and Finance Deal of the Year,” respectively, by IFLR1000.
Mr. Dorsey is a frequent speaker and author on a range of finance topics. He has served as Contributing Editor of multiple editions of Chambers’ Acquisition Finance Guide and authored chapters on the U.S. acquisition finance market. In addition, Mr. Dorsey authored the “Special Considerations for Non-EU Issuers” chapter in the Third Edition of European Securities Law and co‑authored an article entitled “SPAC Transactions in the United States” in The Legal 500’s “Mergers & Acquisitions Country Comparative Guide.” He has spoken at events such as the International Bar Association's “From Start Up to IPO” and “Global Entrepreneurship” conferences, the Practising Law Institute’s “Institute on Securities Regulation” and TechGC’s First-Time GC Summit.
Mr. Dorsey is a member of the International Bar Association and serves as the North American Regional Forum Liaison Officer of the Closely Held Companies Committee.
Mr. Dorsey was born in Canton, Ohio. He received a B.S. and M.Acc. summa cum laude from Case Western Reserve University in 2006 and a J.D. summa cum laude from Cornell Law School in 2009, where he was a Notes Editor of the Law Review and was elected to the Order of the Coif.
Mr. Dorsey joined Cravath in 2009 and was elected a partner in 2017. He worked in the Firm’s London office from 2011 to 2013 and is currently based in the Firm’s New York office.
International Bar Association
New York City Bar Association
New York State Bar Association
Bloomberg Law
Chambers Global
Chambers USA
IFLR1000
Law360
The Legal 500 US
Deals & Cases
March 08, 2024
Cravath represented the underwriters in connection with the $500 million registered senior notes offering of CBRE Services, Inc., a direct wholly‑owned subsidiary of CBRE Group, Inc. CBRE is the world’s largest commercial real estate services and investment firm, based on 2022 revenue. The transaction closed on February 23, 2024.
Deals & Cases
February 01, 2024
On February 1, 2024, DRI Healthcare Trust (“the Trust”), a global leader in providing financing to advance innovation in the life sciences industry, announced it has expanded its interest in royalties on the U.S. net sales of Omidria® by amending its existing agreement with Omeros Corporation ("Omeros") for $115 million on closing and up to $55 million in potential sales‑based milestone payments. As a result, the Trust will now receive 100% of Omeros’s royalties on the U.S. net sales of Omidria® through December 31, 2031. Cravath is representing DRI Healthcare Trust in connection with the transaction.
Deals & Cases
October 02, 2023
Cravath represented Nestlé Holdings, Inc. in connection with its $1.5 billion 144A/Reg. S notes offering, guaranteed by Nestlé S.A, the world's largest food and beverage company. Proceeds of the offering were used for general corporate purposes of the Nestlé Group. The transaction closed on September 12, 2023.
Deals & Cases
August 15, 2023
On August 14, 2023, DRI Healthcare Trust, a global leader in providing financing to advance innovation in the life sciences industry, managed by DRI Capital Inc., announced that it has purchased a second royalty interest in the worldwide net sales of ORSERDU®, the first approved targeted therapy used in the treatment of postmenopausal women or adult men with advanced or metastatic breast cancer who have experienced disease progression despite prior endocrine therapy. DRI Healthcare entered into a purchase agreement with Radius Pharmaceuticals, Inc., a wholly owned subsidiary of Radius Health, Inc. for an upfront purchase price of $130 million. In addition to running royalties, DRI Healthcare is also entitled to receive milestone payments of up to $40 million on the achievement of sales performance thresholds. Cravath represented DRI Capital Inc. in connection with the transaction.
Deals & Cases
July 17, 2023
On July 17, 2023, Proximus Group announced that it has signed a definitive agreement to acquire, through Proximus Opal, an approximately 58% interest in Route Mobile, a global company specialized in CPaaS services, from the founding shareholders of Route Mobile. As part of the agreement, some of the founding shareholders will reinvest in a minority stake in Proximus Opal, a subsidiary of the Proximus Group and the holding company of Telesign, Proximus’s U.S.‑based affiliate. Cravath, alongside Slaughter and May, AZB & Partners and NautaDutilh, is representing Route Mobile and its founding shareholders in connection with the transaction.
Activities & Publications
February 08, 2024
On January 29, 2024, Cravath prepared a memo for its clients entitled “SEC Adopts New Rules and Amendments for SPACs, Shell Companies and Projections.” The memo examines the U.S. Securities and Exchange Commission’s recently adopted rules and amendments to enhance disclosures and provide additional investor protections in connection with initial public offerings by special purpose acquisition companies and in subsequent business combination transactions between SPACs and target companies. The memo outlines the new requirements related to forward‑looking statements and projections, compliance dates, key takeaways for companies and more.
Activities & Publications
February 07, 2024
On February 2, 2024, Cravath published a memo for its clients entitled “Potential FSOC Scrutiny of ‘Big Tech’ Firms.”
Activities & Publications
November 03, 2023
Cravath partners Margaret T. Segall, Nicholas A. Dorsey and G.J. Ligelis Jr. spoke at the International Bar Association’s 2023 Annual Conference, which was held from October 29 to November 3, 2023, in Paris and convened legal professionals from across the globe.
Activities & Publications
October 19, 2023
On October 12, 2023, Cravath hosted its fifth annual Global Enforcement Forum at its offices in New York. The event brought together investigations and regulatory lawyers from the Firm and leading foreign firms across the globe for a series of presentations, panel discussions and roundtables examining significant developments in enforcement.
Activities & Publications
August 29, 2023
On July 27, 2023, Cravath partner Nicholas A. Dorsey was featured in Bloomberg Law’s “They’ve Got Next: 40 Under 40” series, which recognizes “the accomplishments of stellar young lawyers nationwide,” based on their work on key client matters, assumption of leadership roles, pro bono commitments and more. In a Q&A, Nick, the only capital markets‑focused lawyer included on the list for 2023, described his work on financings relating to “transformative, bet‑the‑company situations,” including for client PG&E in an $8.72 billion tri‑tranche equity offering—the largest utility equity offering in history. Nick highlighted his pride in helping to advance the profession of practicing law, including through mentorship of young lawyers and activity in the International Bar Association, and noted the significant impact of his own greatest mentor in the law, Cravath partner Craig Arcella.
Nicholas A. Dorsey focuses his practice on representing corporate issuers and borrowers, and financial institutions, lenders and other parties, in public and private offerings of securities, loan transactions and other financing transactions. He also represents companies in mergers and acquisitions and regularly advises clients in connection with public disclosure and corporate matters. Additionally, Mr. Dorsey dedicates a significant portion of his practice to providing commercial and strategic advice to startup, early‑stage and founder‑led companies and investors in such companies. Clients regularly seek his counsel for the practical, commercial advice he offers with respect to their most challenging matters.
In addition to traditional capital markets offerings and banking transactions, Mr. Dorsey’s financing practice includes advising on liability management transactions and asset financings and securitizations. He has extensive cross‑border experience and counts multiple international companies and financial institutions among his diverse client base.
Notable work highlights include:
Mr. Dorsey has been recognized for his work in capital markets by Chambers USA, Chambers Global, The Legal 500 US and IFLR1000. He has been named to Bloomberg Law’s “40 Under 40” list and was named the “Equity Capital Markets Lawyer of the Year” by IFLR1000 in its United States Awards and a “Rising Star” by Law360, recognizing him as one of five outstanding capital markets lawyers in the nation under the age of 40. Mr. Dorsey’s representations of the Founders of Palantir in the company’s direct listing and PG&E in its $5.5 billion DIP financing have been featured as the “Equity Capital Markets Deal of the Year” and “Banking and Finance Deal of the Year,” respectively, by IFLR1000.
Mr. Dorsey is a frequent speaker and author on a range of finance topics. He has served as Contributing Editor of multiple editions of Chambers’ Acquisition Finance Guide and authored chapters on the U.S. acquisition finance market. In addition, Mr. Dorsey authored the “Special Considerations for Non-EU Issuers” chapter in the Third Edition of European Securities Law and co‑authored an article entitled “SPAC Transactions in the United States” in The Legal 500’s “Mergers & Acquisitions Country Comparative Guide.” He has spoken at events such as the International Bar Association's “From Start Up to IPO” and “Global Entrepreneurship” conferences, the Practising Law Institute’s “Institute on Securities Regulation” and TechGC’s First-Time GC Summit.
Mr. Dorsey is a member of the International Bar Association and serves as the North American Regional Forum Liaison Officer of the Closely Held Companies Committee.
Mr. Dorsey was born in Canton, Ohio. He received a B.S. and M.Acc. summa cum laude from Case Western Reserve University in 2006 and a J.D. summa cum laude from Cornell Law School in 2009, where he was a Notes Editor of the Law Review and was elected to the Order of the Coif.
Mr. Dorsey joined Cravath in 2009 and was elected a partner in 2017. He worked in the Firm’s London office from 2011 to 2013 and is currently based in the Firm’s New York office.
In addition to traditional capital markets offerings and banking transactions, Mr. Dorsey’s financing practice includes advising on liability management transactions and asset financings and securitizations. He has extensive cross‑border experience and counts multiple international companies and financial institutions among his diverse client base.
Notable work highlights include:
Mr. Dorsey has been recognized for his work in capital markets by Chambers USA, Chambers Global, The Legal 500 US and IFLR1000. He has been named to Bloomberg Law’s “40 Under 40” list and was named the “Equity Capital Markets Lawyer of the Year” by IFLR1000 in its United States Awards and a “Rising Star” by Law360, recognizing him as one of five outstanding capital markets lawyers in the nation under the age of 40. Mr. Dorsey’s representations of the Founders of Palantir in the company’s direct listing and PG&E in its $5.5 billion DIP financing have been featured as the “Equity Capital Markets Deal of the Year” and “Banking and Finance Deal of the Year,” respectively, by IFLR1000.
Mr. Dorsey is a frequent speaker and author on a range of finance topics. He has served as Contributing Editor of multiple editions of Chambers’ Acquisition Finance Guide and authored chapters on the U.S. acquisition finance market. In addition, Mr. Dorsey authored the “Special Considerations for Non-EU Issuers” chapter in the Third Edition of European Securities Law and co‑authored an article entitled “SPAC Transactions in the United States” in The Legal 500’s “Mergers & Acquisitions Country Comparative Guide.” He has spoken at events such as the International Bar Association's “From Start Up to IPO” and “Global Entrepreneurship” conferences, the Practising Law Institute’s “Institute on Securities Regulation” and TechGC’s First-Time GC Summit.
Mr. Dorsey is a member of the International Bar Association and serves as the North American Regional Forum Liaison Officer of the Closely Held Companies Committee.
Mr. Dorsey was born in Canton, Ohio. He received a B.S. and M.Acc. summa cum laude from Case Western Reserve University in 2006 and a J.D. summa cum laude from Cornell Law School in 2009, where he was a Notes Editor of the Law Review and was elected to the Order of the Coif.
Mr. Dorsey joined Cravath in 2009 and was elected a partner in 2017. He worked in the Firm’s London office from 2011 to 2013 and is currently based in the Firm’s New York office.
International Bar Association
New York City Bar Association
New York State Bar Association
Bloomberg Law
Chambers Global
Chambers USA
IFLR1000
Law360
The Legal 500 US
Deals & Cases
March 08, 2024
Cravath represented the underwriters in connection with the $500 million registered senior notes offering of CBRE Services, Inc., a direct wholly‑owned subsidiary of CBRE Group, Inc. CBRE is the world’s largest commercial real estate services and investment firm, based on 2022 revenue. The transaction closed on February 23, 2024.
Deals & Cases
February 01, 2024
On February 1, 2024, DRI Healthcare Trust (“the Trust”), a global leader in providing financing to advance innovation in the life sciences industry, announced it has expanded its interest in royalties on the U.S. net sales of Omidria® by amending its existing agreement with Omeros Corporation ("Omeros") for $115 million on closing and up to $55 million in potential sales‑based milestone payments. As a result, the Trust will now receive 100% of Omeros’s royalties on the U.S. net sales of Omidria® through December 31, 2031. Cravath is representing DRI Healthcare Trust in connection with the transaction.
Deals & Cases
October 02, 2023
Cravath represented Nestlé Holdings, Inc. in connection with its $1.5 billion 144A/Reg. S notes offering, guaranteed by Nestlé S.A, the world's largest food and beverage company. Proceeds of the offering were used for general corporate purposes of the Nestlé Group. The transaction closed on September 12, 2023.
Deals & Cases
August 15, 2023
On August 14, 2023, DRI Healthcare Trust, a global leader in providing financing to advance innovation in the life sciences industry, managed by DRI Capital Inc., announced that it has purchased a second royalty interest in the worldwide net sales of ORSERDU®, the first approved targeted therapy used in the treatment of postmenopausal women or adult men with advanced or metastatic breast cancer who have experienced disease progression despite prior endocrine therapy. DRI Healthcare entered into a purchase agreement with Radius Pharmaceuticals, Inc., a wholly owned subsidiary of Radius Health, Inc. for an upfront purchase price of $130 million. In addition to running royalties, DRI Healthcare is also entitled to receive milestone payments of up to $40 million on the achievement of sales performance thresholds. Cravath represented DRI Capital Inc. in connection with the transaction.
Deals & Cases
July 17, 2023
On July 17, 2023, Proximus Group announced that it has signed a definitive agreement to acquire, through Proximus Opal, an approximately 58% interest in Route Mobile, a global company specialized in CPaaS services, from the founding shareholders of Route Mobile. As part of the agreement, some of the founding shareholders will reinvest in a minority stake in Proximus Opal, a subsidiary of the Proximus Group and the holding company of Telesign, Proximus’s U.S.‑based affiliate. Cravath, alongside Slaughter and May, AZB & Partners and NautaDutilh, is representing Route Mobile and its founding shareholders in connection with the transaction.
Activities & Publications
February 08, 2024
On January 29, 2024, Cravath prepared a memo for its clients entitled “SEC Adopts New Rules and Amendments for SPACs, Shell Companies and Projections.” The memo examines the U.S. Securities and Exchange Commission’s recently adopted rules and amendments to enhance disclosures and provide additional investor protections in connection with initial public offerings by special purpose acquisition companies and in subsequent business combination transactions between SPACs and target companies. The memo outlines the new requirements related to forward‑looking statements and projections, compliance dates, key takeaways for companies and more.
Activities & Publications
February 07, 2024
On February 2, 2024, Cravath published a memo for its clients entitled “Potential FSOC Scrutiny of ‘Big Tech’ Firms.”
Activities & Publications
November 03, 2023
Cravath partners Margaret T. Segall, Nicholas A. Dorsey and G.J. Ligelis Jr. spoke at the International Bar Association’s 2023 Annual Conference, which was held from October 29 to November 3, 2023, in Paris and convened legal professionals from across the globe.
Activities & Publications
October 19, 2023
On October 12, 2023, Cravath hosted its fifth annual Global Enforcement Forum at its offices in New York. The event brought together investigations and regulatory lawyers from the Firm and leading foreign firms across the globe for a series of presentations, panel discussions and roundtables examining significant developments in enforcement.
Activities & Publications
August 29, 2023
On July 27, 2023, Cravath partner Nicholas A. Dorsey was featured in Bloomberg Law’s “They’ve Got Next: 40 Under 40” series, which recognizes “the accomplishments of stellar young lawyers nationwide,” based on their work on key client matters, assumption of leadership roles, pro bono commitments and more. In a Q&A, Nick, the only capital markets‑focused lawyer included on the list for 2023, described his work on financings relating to “transformative, bet‑the‑company situations,” including for client PG&E in an $8.72 billion tri‑tranche equity offering—the largest utility equity offering in history. Nick highlighted his pride in helping to advance the profession of practicing law, including through mentorship of young lawyers and activity in the International Bar Association, and noted the significant impact of his own greatest mentor in the law, Cravath partner Craig Arcella.
Celebrating 200 years of partnership. In 2019, we celebrated our bicentennial. Our history mirrors that of our nation. Integral to our story is our culture.
Attorney Advertising. ©2024 Cravath, Swaine & Moore LLP.